CXCL12-γ expression is inhibited in neuroinflammation

Area of Science:

• Neuroimmunology
• Molecular and Cellular Biology

Background:

• Chemokine C-X-C motif ligand 12 (CXCL12) has known protective roles in the central nervous system (CNS) during autoimmune conditions.
• CXCL12-gamma (CXCL12-γ) is a distinct isoform with unique properties, and its role in neuroinflammation requires further elucidation.

Purpose of the Study:

• To investigate the expression of CXCL12-γ in the CNS during experimental autoimmune encephalomyelitis (EAE).
• To determine the regulatory role of nitric oxide (NO) in CNS CXCL12-γ expression in the context of neuroinflammation.

Main Methods:

• Quantitative analysis of CXCL12-γ expression in spinal cord homogenates and isolated micro-blood vessels from EAE-prone (Dark Agouti) and EAE-resistant (Albino Oxford) rats.
• In vitro studies assessing the effect of NO modulation (inhibition or donation) on CXCL12-γ expression in astrocytes.
• Investigation for a specific nucleolar-migrating splice variant of CXCL12-γ.

Main Results:

• CNS CXCL12-γ expression was significantly lower in EAE-prone rats compared to EAE-resistant rats.
• Nitric oxide (NO) synthesis inhibition upregulated CXCL12-γ in Dark Agouti rats, while NO donation downregulated it in Albino Oxford rats.
• In vitro, NO was found to inhibit CXCL12-γ expression in astrocytes. A nucleolar splice variant was not detected.

Conclusions:

• CXCL12-γ is expressed in the CNS following EAE induction but is suppressed during severe spinal cord inflammation.
• Nitric oxide (NO) acts as a key regulator of CXCL12-γ expression in the context of neuroinflammation.
• These findings highlight a novel regulatory mechanism in CNS autoimmunity involving CXCL12-γ and NO.